Retrieve available abstracts of 22 articles: HTML format
Single Articles
November 2025
LUO X, Wei Y, Lin H, Xiao N, et al BUB1B promotes homologous recombination?mediated DNA damage repair in breast
cancer cells through the PI3K/AKT signaling pathway.
Oncol Rep. 2025;54:147. PubMedAbstract available
CHEN T, Sun S, Zhou Z, Zhang X, et al Ursolic acid: A natural pentacyclic triterpenoid with clinical promise in
gynecological and breast cancers (Review).
Oncol Rep. 2025;54:153. PubMedAbstract available
September 2025
LI T, Zhang C, Ding Y, Zhai W, et al [Corrigendum] Umbilical cord?derived mesenchymal stem cells promote proliferation
and migration in MCF?7 and MDA?MB?231 breast cancer cells through activation of
the ERK pathway.
Oncol Rep. 2025;54:100. PubMedAbstract available
CIARAMELLA V, Carrese B, Coppola L, Smaldone G, et al Evaluation of HMGB1 as possible marker via breast organoid cultures research.
Oncol Rep. 2025;54:106. PubMedAbstract available
July 2025
ZUO X, Qin Y, Zhang X, Ning Q, et al [Retracted] Breast cancer cells are arrested at different phases of the cell
cycle following the re?expression of ARHI.
Oncol Rep. 2025;54:83. PubMedAbstract available
June 2025
XIAO L, Li J, Liao J, Wu M, et al BCL2A1? and G0S2?driven neutrophil extracellular traps: A protective mechanism
linking preeclampsia to reduced breast cancer risk.
Oncol Rep. 2025;53:64. PubMedAbstract available
March 2025
DU SM, Li N, Xu WJ, Liu K, et al Triple?negative breast cancer cell?derived piR?31115 promotes the proliferation
and migration of endothelial cells via METTL3?mediated m6A modification of YAP1.
Oncol Rep. 2025;53:34. PubMedAbstract available
February 2025
ZHANG X, Cui D, Sun W, Yang G, et al Regulation of the beta?catenin/LEF?1 pathway by the siRNA knockdown of RUVBL1
expression inhibits breast cancer cell proliferation, migration and invasion.
Oncol Rep. 2025;53:22. PubMedAbstract available
January 2025
HAN R, Zhao J, Lu L [Retracted] MicroRNA?34a expression affects breast cancer invasion in vitro and
patient survival via downregulation of E2F1 and E2F3 expression.
Oncol Rep. 2025;53:8. PubMedAbstract available
DAI X, Geng F, Li M, Liu M, et al [Corrigendum] Tripartite motif?containing 11 regulates the proliferation and
apoptosis of breast cancer cells.
Oncol Rep. 2025;53:5. PubMedAbstract available
WANG YW, Tuan YL, Wang JY, Chang HY, et al Potential of epithelial membrane protein 3 as a novel therapeutic target for
human breast cancer.
Oncol Rep. 2025;53:16. PubMedAbstract available
December 2024
HU F, Zhang Y, Li M, Zhao L, et al [Corrigendum] BMP?6 inhibits the metastasis of MDA?MB?231 breast cancer cells by
regulating MMP?1 expression.
Oncol Rep. 2024;52:163. PubMedAbstract available
November 2024
SUN P, Huang H, Ma JC, Feng B, et al Repurposing propofol for breast cancer therapy through promoting apoptosis and
arresting cell cycle.
Oncol Rep. 2024;52:155. PubMedAbstract available
October 2024
CUI H, Yuan J, Du X, Wang M, et al [Corrigendum] Ethyl gallate suppresses proliferation and invasion in human breast
cancer cells via Akt?NF?kappaB signaling.
Oncol Rep. 2024;52:128. PubMedAbstract available
ZHAO Z, Sun YS, Chen W, Lv LX, et al [Corrigendum] Hispolon inhibits breast cancer cell migration by reversal of
epithelial?to?mesenchymal transition via suppressing the ROS/ERK/Slug/E?cadherin
pathway.
Oncol Rep. 2024;52:134. PubMedAbstract available
September 2024
QIU Y, Liu Y, Li WH, Zhang HQ, et al [Corrigendum] P2Y2 receptor promotes the migration and invasion of breast cancer
cells via EMT?related genes Snail and E?cadherin.
Oncol Rep. 2024;52:111. PubMedAbstract available
August 2024
LIM JS, Kim E, Song JS, Ahn S, et al Energy?stress?mediated activation of AMPK sensitizes MPS1 kinase inhibition in
triple?negative breast cancer.
Oncol Rep. 2024;52:101. PubMedAbstract available
LI H, Li X, Du W Interplay between Wnt signaling molecules and exosomal miRNAs in breast cancer
(Review).
Oncol Rep. 2024;52:107. PubMedAbstract available
PENG X, Ma L, Chen X, Tang F, et al Inhibition of FBP1 expression by KMT5A through TWIST1 methylation is one of the
mechanisms leading to chemoresistance in breast cancer.
Oncol Rep. 2024;52:110. PubMedAbstract available
July 2024
YAO J, Xu T, Tian T, Fu X, et al [Retracted] Tripartite motif 16 suppresses breast cancer stem cell properties
through regulation of Gli?1 degradation via the ubiquitin?proteasome pathway.
Oncol Rep. 2024;52:89. PubMedAbstract available
YANG X, Liang B, Zhang L, Zhang M, et al Ursolic acid inhibits the proliferation of triple?negative breast cancer
stem?like cells through NRF2?mediated ferroptosis.
Oncol Rep. 2024;52:94. PubMedAbstract available
ANWAR S, Zafar M, Hussain MA, Iqbal N, et al Unravelling the therapeutic potential of forkhead box proteins in breast cancer:
An update (Review).
Oncol Rep. 2024;52:92. PubMedAbstract available